Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Shouval

Showing results (91-100 of 98) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 98 results.
Hepatology (Baltimore, Md.)|March 1, 2002
Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral propertiesEithan Galun, Rachel Eren, Rifaat Safadi, et al.
Hepatology (Baltimore, Md.)|July 31, 2008
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis CStefan Zeuzem, Eric M Yoshida, Yves Benhamou, et al.
Hepatology (Baltimore, Md.)|May 22, 2012
Tracing hepatitis B virus to the 16th century in a Korean mummyGila Kahila Bar-Gal, Myeung Ju Kim, Athalia Klein, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for retreatment of HCV infectionStefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for previously untreated chronic hepatitis C virus infectionIra M Jacobson, John G McHutchison, Geoffrey Dusheiko, et al.
Human Vaccines & Immunotherapeutics|December 11, 2025
The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birthPierre Van Damme, Greet Hendrickx, Sakshi Jindal, et al.
Journal of Hepatology|August 22, 2008
Statements from the Taormina expert meeting on occult hepatitis B virus infectionGiovanni Raimondo, Jean-Pierre Allain, Maurizia R Brunetto, et al.
Journal of Hepatology|April 8, 2023
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countriesHomie A Razavi, Maria Buti, Norah A Terrault, et al.
Pageof 10

Showing results (91-100 of 98) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 98 results.
Hepatology (Baltimore, Md.)|March 1, 2002
Clinical evaluation (phase I) of a combination of two human monoclonal antibodies to HBV: safety and antiviral propertiesEithan Galun, Rachel Eren, Rifaat Safadi, et al.
Hepatology (Baltimore, Md.)|July 31, 2008
Albinterferon alfa-2b dosed every two or four weeks in interferon-naïve patients with genotype 1 chronic hepatitis CStefan Zeuzem, Eric M Yoshida, Yves Benhamou, et al.
Hepatology (Baltimore, Md.)|May 22, 2012
Tracing hepatitis B virus to the 16th century in a Korean mummyGila Kahila Bar-Gal, Myeung Ju Kim, Athalia Klein, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for retreatment of HCV infectionStefan Zeuzem, Pietro Andreone, Stanislas Pol, et al.
The New England Journal of Medicine|June 24, 2011
Telaprevir for previously untreated chronic hepatitis C virus infectionIra M Jacobson, John G McHutchison, Geoffrey Dusheiko, et al.
Human Vaccines & Immunotherapeutics|December 11, 2025
The Viral Hepatitis Prevention Board (VHPB) supports the continued recommendation for universal hepatitis B vaccination of all newborns within 24 hours of birthPierre Van Damme, Greet Hendrickx, Sakshi Jindal, et al.
Journal of Hepatology|August 22, 2008
Statements from the Taormina expert meeting on occult hepatitis B virus infectionGiovanni Raimondo, Jean-Pierre Allain, Maurizia R Brunetto, et al.
Journal of Hepatology|April 8, 2023
Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countriesHomie A Razavi, Maria Buti, Norah A Terrault, et al.
Pageof 10